Shi-Yu Wu

Construction and internal validation of a risk prediction model for rapid bone loss during aromatase inhibitor therapy

This single-center study developed an exploratory prediction model that, after optimism correction, showed modest discrimination and may serve as a preliminary screening framework to identify postmenopausal patients at high risk of rapid bone loss related to early AI therapy.